Curriculum
Training and location overview
The program of training in gynecologic oncology is 36-months, including 24 months devoted to clinical gynecologic oncology and 12 months dedicated to research which includes required core graduate-level didactics.
The main site for the gynecology oncology fellowship will be Corewell Health William Beaumont University Hospital, Royal Oak. We also use three additional sites at Corewell Health: Dearborn, Troy and Grosse Pointe.
Didactics and organization curriculum
| Didactic Activity | R/R/S/O | Fellowship Level? (Yes/No) | Who is Responsible for Planning the Activity? | Frequency/Duration |
| Journal Club | R | Yes | Gyn Oncology Faculty | Quarterly/2 Hours |
| Protected Fellow Educational Didactics | R | Yes | Gyn Oncology Faculty | Weekly/3 Hours |
| Gyn Onc Tumor Board Multidisciplinary | R | Yes | Gyn Oncology Faculty | Weekly/1 Hour |
| Morbidity and Mortality Patient Care Conference | R | No | Departmental | Monthly/1 Hour |
| Surgical Planning/ERAS Conference | R | Yes | Gyn Oncology Faculty | Weekly/1 Hour |
| Lectures | R | Yes | Gyn Oncology Faculty | Weekly/1 Hour |
| Clinical Case Review Conference | R | Yes | Gyn Oncology Faculty | Monthly/1 Hour |
| Seminars | R | Yes | Gyn Oncology Faculty | Semi-annually to Annually/3 Hours |
| Grand Rounds | RS | No | Department Chair | Weekly/1 Hour |
| Resident Didactic Teaching | RS | No | Fellow and Faculty | Weekly/2 Hours |
Tumor board
A prospective multidisciplinary tumor board for gynecologic oncology takes place weekly.
The session is attended by staff from gynecologic oncology, radiation oncology, pathology, medical oncology, radiology, research coordinators, and other allied health services. The fellows will supervise the residents in their formal presentations and assist with the development of a treatment plan or discussion of potential therapies. All postoperative cases are presented, as well as those cases in follow-up needing additional strategic input regarding imaging review or treatment modifications. Following detailed review of the history, imaging studies, and pertinent pathology, management options will be proposed by the residents and fellows and then discussed by the tumor board as a whole. During this discussion, fellows will be asked additional questions about the disease process, relevant clinical trials, and potential side effects of the therapies suggested. Subsequently, the recommendations are presented to the patient in the clinical setting. Fellows will be central throughout this critical patient-centered and educational process and will use this opportunity to demonstrate their critical thinking abilities, knowledge of the disease process, and knowledge of the sentinel studies/data that supports their recommendations.